Veeva Systems Inc.

US$303.73As of Sun 8 Nov 2026, 12:00 UTC

NYSE:VEEVHealthcare

Country USA

PE (Fwd) •••

TSR 10Y CAGR 22.78%

Div yield —

ROE 14.42%

Health Information Services

Beta (5Y) 0.88

PE TTM 49.79

TSR TTM 4.30%

Mkt cap US$49.18B

ROIC 95.58%

SE Grade™

Value

Quality

Moat

Consensus

Reference

$366

20.43%

1.71%

Hold 3|3|6|7|1

TTM

FYE 31 Jan USD

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026

FY2027E

Trend

10Y

Peers

8.318

Revenue$B

7.994

8.755

9.264

10.16

11.12

12.13

13.33

14.48

15.62

16.60

9.199

8.33%

8.35%

21.10

Revenue growth%

1.62

0.62

1.10

2.35

1.05

0.40

7.22

0.40

0.51

12.52

Gross margin%

19.31

22.23

23.26

25.89

24.14

22.64

24.37

24.01

22.75

22.41

11.95

22.75

23.00

17.05

Operating margin%

31.31

32.31

32.40

30.91

29.54

28.07

27.50

29.64

32.36

34.11

9.77

29.64

31.11

15.17

Net margin%

16.51

19.44

22.36

21.12

21.17

21.86

20.18

19.87

21.59

18.82

4.48

20.18

20.65

18.73

P/E ratio (avg)x

5.327

5.529

5.357

5.300

4.682

3.953

4.033

3.526

3.181

3.334

7.319

3.526

4.357

16.53

EV/EBITx

24.56

26.60

30.67

31.86

33.48

33.10

31.00

32.62

31.12

33.01

28.50

32.62

31.49

11.90

FCF yield (avg)%

15.97

16.89

19.84

21.69

19.72

19.59

17.17

17.37

18.43

21.05

11.74

18.43

19.01

6.32

FCF margin%

1.85

2.73

5.12

4.69

2.81

3.21

2.32

4.66

3.10

2.14

7.10

3.10

2.96

0.558

FCF / Net incomex

0.223

0.215

0.232

0.268

0.282

0.292

0.283

0.270

0.301

0.350

0.812

0.292

0.276

8.66

ROIC%

13.90

14.90

13.02

14.03

15.88

18.58

21.08

21.72

23.71

26.58

27.87

21.72

17.23

26.28

Return on equity%

6.97

8.90

6.30

7.43

7.25

7.11

5.50

5.18

6.28

3.35

14.16

5.50

6.63

6.61

Return on assets%

11.89

12.67

15.31

16.00

13.31

11.25

12.16

12.30

11.09

10.16

20.39

11.25

12.23

40.24

EPS$

31.05

30.39

32.85

33.93

30.05

30.23

28.49

25.21

25.98

24.12

44.96

(4.30%)

(3.12%)

—

11.07

EPS growth%

14.97

17.45

14.49

12.04

14.64

16.30

19.08

21.32

22.45

24.76

16.13

21.32

16.87

20.92

Bookvalue per sh$

22.46

21.60

21.72

24.03

23.19

22.65

20.12

19.49

21.01

23.16

30.29

(0.02%)

(0.46%)

—

18.25

FCF per share$

11.31

12.04

13.17

15.50

18.59

19.90

19.99

19.44

20.61

23.80

16.17

5.06%

7.67%

—

8.13

Dividend per sh$

15.68

14.30

12.88

12.56

11.10

10.15

10.65

10.39

9.53

10.32

25.97

(1.45%)

(3.91%)

—

27.76

Div yield (avg)%

27.88

29.65

32.46

34.34

34.42

34.70

34.14

34.58

32.06

33.05

16.29

34.14

33.60

24.03

Payout ratio%

4.53

4.89

4.13

1.45

1.13

2.06

0.40

0.91

3.17

5.16

13.67

2.06

2.62

159.1

Shares (diluted)M

229.5

236.8

270.9

278.6

296.6

294.0

340.6

407.5

453.1

453.3

164.3

8.86%

7.58%

4.27

Buyback yield%

22.13

24.41

24.30

22.44

24.67

23.00

24.48

25.52

22.55

21.70

24.43

23.00

23.65

1.756

D/E ratiox

0.394

0.355

0.373

0.410

0.459

0.485

0.456

0.519

0.498

0.472

1.771

0.485

0.458

6.297

Enterprise value$B

4.668

5.183

5.591

6.296

6.264

6.330

7.266

7.968

8.110

7.843

10.76

4.60%

6.05%

12.05

LT debt$B

14.93

17.09

16.60

17.59

19.01

17.95

18.23

16.78

15.52

17.30

4.534

(1.87%)

2.04%

Peers (US$49.18B)

Cap (US$)

BrightSpring Health…

13.99B

36.42x

Tempus AI, Inc.

13.87B

—

Hinge Health, Inc.

9.341B

58.26x

Humana Inc.

52.09B

42.18x

Capital

TTM

10Y

Leveragex

0.650

0.145

0.121

EBIT/Intx

1.719

1.391

1.126

Own earn%

(21.89)

(1.68)

(9.76)

Sh yield%

32.02

57.69

56.77

Owners

Insiders/Inst%

5.09

26.75

Short interest%

0.89

SBC / revenue%

5.39

Record

10Y

Profitable years

10/10

Revenue growth years

10/10

EPS growth years

10/10

Dividend streakyrs

Op margin range%

28–34

$1 testx

−0.1

Incr. ROIC%

Veeva Systems Inc. provides cloud-based software for the life sciences industry across North America, Europe, Asia Pacific, the Middle East, Africa and Latin America, offering Commercial Cloud, Data Cloud and Development Cloud products such as CRM for pharmaceutical and biotechnology companies, alongside Quality Cloud for life sciences and consumer products firms, plus consulting, implementation, training and managed services.

Growth vs revenue

Latest

Trend

10Y CAGR

Rel growth

Revenue

$16.60B

8.35%

1.00×

Cost of revenue

$7.783B

8.70%

1.03×

Operating expenses

$3.303B

7.76%

0.95×